AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 64 min read$CYRX

Cryoport, Inc. (CYRX): Results of Operations and Financial Condition

Cryoport, Inc. (CYRX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622464d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Cryoport Reports Second Quarter 2026 Financial Results · Second quarter revenue grew 8% year-over-year to $49.0 million · Life Sciences Services revenue increased 15% year-over-year · BioStorage/BioServices revenue grew 2

Original reporting
SEC EDGAR 8-K
Published Aug 6, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$CYRX
Bullish
medium confidence
Mentioned
$CYRX
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CYRXBullishMed
01

Why it matters

Traders can update CYRX’s growth mix (services up, products flat) and incorporate the stated adjusted EBITDA inflection when reassessing margin trajectory and operating leverage.

02

Market read

The quarter’s revenue growth and the claim of positive adjusted EBITDA are the key new datapoints for CYRX’s near-term valuation and margin expectations.

03

What to watch

The filing references upcoming facility/network expansion and product launches, but does not quantify margin guidance or near-term capex, leaving execution risk.

Relevance 7/10Novelty 7/10Timing: filed after market close, for next-session earnings-model repricing

Background

This is Cryoport’s SEC 8-K with Exhibit 99.1 covering Q2 and H1 2026 results and operational milestones tied to its temperature-controlled supply chain for life sciences and CGT.

Company-level read

Ticker impact

$CYRXBullishMedium confidence
Context

Cryoport reported Q2 2026 revenue of $49.0M (+8% YoY) and said it achieved positive adjusted EBITDA in the quarter.

Expected impact

Likely positive bias for CYRX as traders focus on adjusted EBITDA turning positive and continued CGT-related demand.

Evidence & confidence

The filing provides concrete quarterly revenue by segment, CGT trial/support metrics, and a stated adjusted EBITDA milestone, all of which are actionable for earnings-model updates.

Market effects

Sector

Supports the CGT supply-chain services growth narrative and may lift sentiment toward temperature-controlled logistics providers.

Regional

No specific regional macro impact beyond planned facility launches in Paris and Santa Ana.

Global

Global clinical-trial support metrics reinforce demand tied to worldwide CGT pipeline expansion.

Counterpoint

What could challenge this read

Positive adjusted EBITDA may not translate to sustainable GAAP profitability, and Life Sciences Products revenue was flat year over year.

Key entities

  • company
    Cryoport, Inc.

    NASDAQ-listed temperature-controlled supply chain provider for life sciences and CGT; reported Q2 2026 results and adjusted EBITDA milestone.

  • customer
    Orca Bio

    Cryoport customer referenced as receiving FDA approval for TREGZI during Q2 2026.

  • customer
    Vertex Pharmaceuticals

    Cryoport customer referenced as receiving FDA supplemental approval for CASGEVY during Q2 2026.

  • customer
    Verismo Therapeutics

    Referenced as selecting Cryoport Systems’ IntegriCell cryopreservation services.

Read at source← All news

Related articles

AUG 8
$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

yahoo.com6 min
AUG 8
$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

yahoo.com6 min
AUG 8
$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

yahoo.com6 min
AUG 8
$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.

yahoo.com6 min
AUG 8
$CPTMedAI 8/10

Camden Property Trust (CPT) Q2 2026 Earnings Call Transcript

Camden Property Trust (CPT) discussed its Q2 2026 earnings call, focusing on exiting its California multifamily portfolio. According to management, it sold the 19-year-old California portfolio for $1.625 billion, with trailing 12-month FFO and AFFO yields of 5.6% and 5.2%. Camden repurchased $694 million of shares and closed $645 million of acquisitions plus $195 million of awarded acquisitions, reaffirming $6.75/share FFO guidance.

yahoo.com7 min
AUG 8
$UNITMed

Uniti (UNIT) Q2 2026 Earnings Call Transcript

Uniti (UNIT) held its Q2 2026 earnings call, saying demand was strong across categories and highlighting growth in fiber revenue. The company reported total fiber revenue up 10% year over year and Fiber Infrastructure fiber revenue up 6%. Uniti raised its 2026 outlook for new fiber homes to 475,000 to 525,000 and said managed services attachment rose, with 16% of new bookings including it.

yahoo.com7 min